# US 2026/0023083 A1 · Diagnostic method of a skin showing signs of aging

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0023083 A1
- Document ID: US20260023083A1
- Status: Published application
- Kind: A1
- Application number: 19/339,443
- Filed: 2025-09-25
- Published: 2026-01-22
- Earliest claimed: 2017-08-23
- Assignees: L'oreal
- Applicants: L'oreal
- Inventors: Sandra KANANI; Virginie PIFFAUT; Aude FOUCHER; Mark DONOVAN
- Web page: https://patentgrep.com/patent/US20260023083A1

## CPC

- G01N 33/6881: {from skin}
- C12N 15/52: Genes encoding for enzymes or proenzymes
- C12Q 1/6883: for diseases caused by alterations of genetic material
- C12N 2501/70: Enzymes
- G01N 2333/8146: Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
- G01N 2333/96486: Metalloendopeptidases (3.4.24)
- G01N 2800/7042: Aging, e.g. cellular aging
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

This invention related to a method for diagnosing a skin displaying signs of aging, based on measuring the level of expression of the gene encoding the IDE. The present invention also relates to a method for the cosmetic treatment of skin. This invention also relates to a method for identifying a compound for reducing the signs of the aging of the skin as well as a kit.

## Claims

### Claim 1

A treatment method of a skin having signs of aging, in a subject, the method comprising the following steps:
a) measuring the level of expression of the gene encoding the insulin-degrading enzyme (IDE), in a skin sample of the subject; and
b) based on the level of expression of the gene encoding the IDE measured in the step a), determining if the skin of the subject has signs of aging selected from a marked microrelief of the skin, fine lines, appearance of wrinkles and loss of elasticity, and
c) when the skin is identified as having signs of aging selected from a marked microrelief of the skin, fine lines, appearance of wrinkles and loss of elasticity in the step b), treating said skin with a cosmetic composition allowing for the reduction and/or the slowing down of the progression of the signs of aging of the skin.

### Claim 2 (depends on 1)

The method according to claim 1, wherein, the signs of skin aging are selected from elastosis, the appearance of crow's feet wrinkles and the appearance of wrinkles under the eyes.

### Claim 3 (depends on 1)

The method according to claim 1, wherein the skin sample is taken by rubbing the skin surface or using an adhesive surface.

### Claim 4 (depends on 1)

The method according to claim 1, wherein the level of expression of the gene encoding IDE is determined by the level of expression of mRNA of said gene or by measuring the level of expression of the protein encoded by said gene.

### Claim 5 (depends on 1)

The method according to claim 1 wherein the level of expression of the protein encoded by the gene encoding IDE is measured using at least one specific ligand of IDE protein.
